Supriya Lifescience Limited

Listed on the BSE and NSE, founded in 1987 and specialising in active ingredients, with its main plant in the MIDC estate at Lote, Ratnagiri district, and a second at Ambernath. Its portfolio exceeds a hundred products, among them chlorphenamine maleate, cetirizine dihydrochloride, salbutamol sulphate and dextromethorphan hydrobromide. It declares customers in more than 86 countries.